11740 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2008)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3306)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (235)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11740)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer
    Meeting Abstract

    Coleman, J.; Sjoberg, D. D.; Demac, Q.; ODea, C.; McGill, M.; Tracey, A.; Nogueira, L.; Vickers, A.; Estes, C.; Fine, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Real-time data quality assurance analysis for real-world, pan-cancer data
    Meeting Abstract

    Brown, S.; Lee, J.; Pillai, A.; Gandhi, F.; Bahadur, N.; Barton, L.; Chan, K.; Niederhausern, A.; Nichols, C.; Philip, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Use of remote patient monitoring in the care of COVID-positive patients in oncology
    Meeting Abstract

    Pugliese, L.; Garcia, J.; Holland, J. C.; Majeed, J.; Silverman, M.; Moy, M.; Kemeny, E.; Reidy, D. L.; Robson, M. E.; Connor, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Using mobile wearables to establish sleep bioprofiles in newly diagnosed multiple myeloma (MM) patients
    Meeting Abstract

    Hevroni, G.; Mastey, D.; Tavitian, E.; Derkach, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase I study of transarterial chemoembolization of lung metastases
    Meeting Abstract

    Boas, F. E.; Kemeny, N. E.; Sofocleous, C. T.; Yeh, R.; Thompson, V. R.; Hsu, M.; Moskowitz, C. S.; Ziv, E.; Yarmohammadi, H.; Bendet, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Patient-reported financial toxicity following management of localized prostate cancer
    Meeting Abstract

    Imber, B. S.; Tin, A. L.; Vickers, A.; Eastham, J. A.; Zelefsky, M. J.; Ehdaie, B.; Gorovets, D.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing
    Meeting Abstract

    Truong, H.; Breen, K.; Kemel, Y.; Lenis, A. T.; Reisz, P.; Benfante, N.; Ehdaie, B.; Touijer, K. A.; Laudone, V. P.; Scardino, P. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Disparities in pan-cancer patients undergoing germline cancer risk assessment by self-reported race/ethnicity and ancestry
    Meeting Abstract

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Fleischut, M. H.; Latham, A.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Characteristics and probability of survival for patients with advanced melanoma who live five or more years after initial treatment with immune checkpoint blockade (ICB)
    Meeting Abstract

    Loo, K.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Implementing virtual mind-body programming to support cancer patients during COVID-19
    Meeting Abstract

    Mao, J. J. J.; Hung, K. W.; Emard, N.; Polubriaginof, F. C. G.; Lynch, K.; Atkinson, T. M.; Trevino, K. M.; Jensen, C.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save